Virginia Corazzi

Dr. Virginia Corazzi

University of Ferrara, Ferrara, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Hematology Reports
Verified
Journal Article
Open access
PDF file
VCVirginia Corazzi
Virginia Corazzi
AMAndrea Migliorelli
Andrea Migliorelli
Chiara BianchiniChiara Bianchini
Chiara Bianchini
SPStefano Pelucchi
Stefano Pelucchi
Andrea CiorbaAndrea Ciorba
Andrea Ciorba
A relationship between microvascular disorders and sensorineural hearing loss (SNHL) has been widely proposed. The vascular hypothesis, theorized for the onset of sudden SNHL (SSNHL), is among the most acknowledged: a localized acute cochlear damage, of ischemic or haemorrhagic nature, could be considered a causative factor of SSNHL. The aim of this review is to assess (i) the effect on hearing in patients affected by blood coagulation disorders (prothrombotic or haemorrhagic) and (ii) the possible etiopathogenetic mechanisms of the related hearing loss. A PRISMA-compliant review was performed. Medline, Embase, and Cinahl databases were searched from inception to 31 January 2023, and a total of 14 studies have been included in the review. The available data suggest that it is possible to consider clotting disorders as a potential condition at risk for sensorineural hearing loss; in particular, coagulation tests and eventually the assessment of genetic and acquired prothrombotic factors should be recommended in patients with SSNHL. Also, an audiological evaluation should be recommended for patients with blood coagulation disorders presenting cochlear symptoms, especially in those suffering from clotting diseases.

15 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Giovanni CammarotoGiovanni Cammaroto
Giovanni Cammaroto
CMClaudio Moretti
Claudio Moretti
GPGiuseppe Di Prinzio
Giuseppe Di Prinzio
ICIsotta Campomagnani
Isotta Campomagnani
GIGIANNICOLA IANNELLA
GIANNICOLA IANNELLA
CVClaudio Vicini
Claudio Vicini
PURPOSE: The aim of our retrospective study is evaluating the effectiveness of barbed repositioning pharyngoplasty (BRP) in a consecutive cohort of patients and assessing its impact on positional indexes in order to potentially identify specific obstructive sleep apnea (OSA) phenotypes for patients who might benefit more significantly from this intervention. METHODS: A single-center retrospective study with baseline and follow-up type III sleep tests evaluating the Apnea Hypopnea Index (AHI), supine AHI, non-supine AHI, oxygen desaturation index (ODI), mean SaO2, percentage of time spent at SaO2 below 90% (CT90), and lowest oxygen saturation (LOS) were performed. The patients were then divided into groups according to Sher’s criteria and Amsterdam Positional OSA Classification (APOC). Parametric and non-parametric tests and univariate and multivariate analyses were conducted. RESULTS: The study finally included 47 patients. The statistical analysis showed significant improvement in AHI, supine AHI, non-supine AHI, and ODI after surgery. The linear regression showed that high values of baseline AHI, AHI supine, and AHI non supine predict more significant postoperative reductions in AHI, AHI supine, and AHI non supine, respectively. Therapeutic success was achieved in 22 patients out of 47. The logistic regression did not find any independent risk factors for success. The most significant reduction in AHI, supine AHI, and non-supine AHI was observed in the APOC 3 group while the APOC 1 patients experience a substantially lower improvement. CONCLUSIONS: BRP appears to be an effective surgical procedure for the treatment of OSA. The non-positional patients might benefit more from BRP in comparison with positional patients. Moreover, OSA severity should not be considered an absolute contra-indication for this surgical procedure.

31 January 2022 in Auris Nasus Larynx
Verified
Journal Article
Closed access
GMGiuseppe Meccariello
Giuseppe Meccariello
GCGiovanni Cammaroto
Giovanni Cammaroto
GIGiannicola Iannella
Giannicola Iannella
AVAndrea De Vito
Andrea De Vito
ACAndrea Ciorba
Andrea Ciorba
PCPasquale Capaccio
Pasquale Capaccio

1 January 2021 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
Andrea CiorbaAndrea Ciorba
Andrea Ciorba
VCVirginia Corazzi
Virginia Corazzi
MMMichela Melegatti
Michela Melegatti
AMAnna Morgan
Anna Morgan
GPGiulia Pelliccione
Giulia Pelliccione
SBStefania Bigoni
Stefania Bigoni
This paper aims to present a third world case of Non-Syndromic sensorineural hearing loss (NSHL) due to a novel missense variant in COL11A1 gene, defined as DFNA37 non-syndromic hearing loss. The clinical features of a 6-year-old boy affected by a bilateral moderate to severe down-sloping sensorineural hearing loss are presented, as well as the genetic analysis, the latter identifying a heterozygous missense variation in the COL11A1 gene. In addition, in families with autosomal dominant transmission, COL11A1 gene should be considered in the genetic workup of the NSHL with prelingual onset. Cite this article as: Ciorba A, Corazzi V, Melegatti M, Morgan A, Pelliccione G, Giorgia Girotto G, et al. Non-Syndromic Sensorineural Prelingual and Postlingual Hearing Loss due to COL11A1 Gene Mutation. J Int Adv Otol 2021; 17(1): 81-3.

27 December 2024 in Audiology Research
Verified
Journal Article
Open access
PDF file
VCVirginia Corazzi
Virginia Corazzi
LMLucia Belén Musumano
Lucia Belén Musumano
AMAndrea Migliorelli
Andrea Migliorelli
LNLaura Negossi
Laura Negossi
Chiara BianchiniChiara Bianchini
Chiara Bianchini
Andrea CiorbaAndrea Ciorba
Andrea Ciorba
Objectives: The present study aims to identify potential predictive factors for developing sensorineural hearing loss (SNHL) in individuals with congenital Cytomegalovirus (cCMV) infection. Methods: A retrospective study was performed on 50 subjects with cCMV infection (symptomatic and asymptomatic), followed at the Audiology Service of Sant’Anna Hospital (University Hospital of Ferrara). The following data were analyzed: the type of maternal Cytomegalovirus (CMV) infection (primary versus non-primary), time of in utero infection, systemic signs and symptoms or laboratory test anomalies due to cCMV infection, and signs and symptoms of central nervous system (CNS) involvement at birth. In particular, brain ultrasonography and encephalic magnetic resonance imaging (MRI) were evaluated, searching for possible links between imaging findings and SNHL. Results: The statistical analysis showed a significantly higher risk of developing SNHL in subjects with signs and symptoms of CNS involvement at birth (p = 0.009 *). The presence of brain MRI abnormalities significantly influenced the onset of SNHL in patients with symptomatic cCMV infection (p = 0.012 *). Brain ultrasonography, the type of maternal CMV infection, systemic signs/symptoms and laboratory test anomalies at birth, and sex resulted in nonsignificant correlations in the analysis. Conclusions: The presence of neurological symptoms at birth and of detectable abnormalities in brain MRI are predictors of SNHL developing in symptomatic cCMV infection. Further investigation on this topic is necessary.

Verified
Journal Article
Open access
PDF file
AMAndrea Migliorelli
Andrea Migliorelli
Marianna ManuelliMarianna Manuelli
Marianna Manuelli
ATAgnese Maria Tringali
Agnese Maria Tringali
CMClaudio Moretti
Claudio Moretti
VCVirginia Corazzi
Virginia Corazzi
Chiara BianchiniChiara Bianchini
Chiara Bianchini
Background/Objectives: Papillary cancer is the most common thyroid cancer. The development of lateral cervical lymph node metastases (I–V levels) is considered a major cause of recurrence. The aim of this study is to investigate the potential predictive factors for lateral cervical lymph node metastasis and disease recurrence, in order to tailor the clinical approach to these patients. An ROC (Receiver Operating Characteristic) curve has been set to search out a cut-off value for the lymph node ratio (LNR), a ratio of involved lymph nodes-to-examined lymph nodes, that could serve as an index of tumor recurrence. Methods: This was an observational retrospective study. The clinical charts of 43 patients with histopathological diagnosis of papillary thyroid cancer who underwent thyroidectomy with lateral and central neck dissection have been reviewed. These results have also been compared with those who underwent total thyroidectomy alone that served as a control group. Results: Extrathyroidal extension (p-value < 0.001), tumor size (p-value = 0.015), number of lymph nodes involvement (p-value = 0.022), and LNR (p-value = 0.004) were identified as potential predictors of tumor recurrence. The ROC curve revealed that an LNR value exceeding 0.205 is indicative of disease recurrence, with an Area Under the Curve (AUC) of 0.818, a sensitivity of 82%, and a specificity of 81%. Furthermore, fT4 value (p-value = 0.008), tumor size (p-value = 0.019), and alcohol consumption (p-value < 0.001) may serve as potential predictors of lymph node metastasis. Conclusions: Extrathyroidal extension, vascular invasion, tumor size, number of pathological lymph nodes, and LNR are associated with recurrence of papillary thyroid carcinoma; in particular, the lymph node ratio can be considered an effective indicator of recurrence risk.